Announcement on the Progress of Half Repurchase Period
Filed with SSE · · 2 pages · Chinese
Shanghai Medicilon, Inc. on 6ix
Earlier from Shanghai Medicilon
- Announcement on Preliminary Earnings Estimate for 2024
- Announcement on Postponing Some Investment Projects Financed by Raised Funds
- Annual Earnings Preannouncement for 2024
- Announcement on Electing Chairman, Chairman of the Board of Supervisors, and Members of Special Committees of the Board of Directors, and Appointing Senior Management Members and Securities Affairs Representative
- Announcement on Shareholdings of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Restrictions Concerning Share Repurchase
Later from Shanghai Medicilon
- Announcement on Provision for Asset Impairment and Write-off of Assets in 2024
- Announcement on Initially Repurchasing the Company's Shares through Call Auction
- Announcement on Attending the Annual Collective Performance Briefing for Innovative Drug Industry on SSE STAR Market 2024 and Convening Q1 2025 Performance Briefing
- Announcement on Share Reduction Plan for Shareholder
- Announcement on Resolution of the 2024 Annual General Meeting
Follow Shanghai Medicilon into a list and get an email when it puts out news.
Follow Shanghai Medicilon